CalendarHerantis Pharma's financial year is the calendar year. During the year, the company publishes an Annual Financial Statements Release and one Interim Report related to accounting period’s first six months. The Financial Statements and Interim Reports will be released around at 9.00 a.m. (Finnish time) on the given dates.
During the Silent period, the Company will not comment on its financial position, markets or outlooks. During the Silent period, the management will neither meet with capital market or financial media representatives, nor take a stand on matters concerning the Company's financial position or general outlooks.
|1 Jul 2019||Herantis newsletter for May-June|
|29 Jul - 27 Aug 2019||Silent period|
|29 Jul - 27 Aug 2019||Closed window|
|21-22 Aug 2019||Herantis attending Neurotrophic Factors meeting in Grand Rapids|
|28 Aug 2019||Interim report on January-June 2019|
|2 Sep 2019||Herantis newsletter for July-August|
|10 Sep 2019||Company presentation to Swedish investors at Aktiespararna's event in Stockholm|
|11-12 Sep 2019||Meet Herantis at NLSDays in Malmö Sweden|
|18 Sep 2019||Company presentation to investors at Life Science Investor Meetings in Copenhagen|
|19 Sep 2019||Company presentation at Sijoittaja 2019|
|28 Sep 2019||Company presentation at Turun talouspäivät|
|4 Nov 2019||Herantis newsletter for September-October|
|11-13 Nov 2019||Meet Herantis at BioEurope in Berlin Germany|
During the Closed window period, trading of Herantis Pharma shares or derivatives is forbidden for the Insider group.